C-Rad AB (publ) (CRAD-B) - Total Assets
Based on the latest financial reports, C-Rad AB (publ) (CRAD-B) holds total assets worth Skr500.80 Million SEK (≈ $53.89 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore C-Rad AB (publ) cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
C-Rad AB (publ) - Total Assets Trend (2008–2025)
This chart illustrates how C-Rad AB (publ)'s total assets have evolved over time, based on quarterly financial data. See C-Rad AB (publ) shareholders equity for net asset value and shareholders' equity analysis.
C-Rad AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2025)
C-Rad AB (publ)'s total assets of Skr500.80 Million consist of 87.5% current assets and 12.5% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 34.2% |
| Accounts Receivable | Skr157.70 Million | 31.5% |
| Inventory | Skr45.70 Million | 9.1% |
| Property, Plant & Equipment | Skr23.80 Million | 4.8% |
| Intangible Assets | Skr39.00 Million | 7.8% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how C-Rad AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see CRAD-B market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: C-Rad AB (publ)'s current assets represent 87.5% of total assets in 2025, an increase from 44.2% in 2008.
- Cash Position: Cash and equivalents constituted 34.2% of total assets in 2025, up from 33.8% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, unchanged from 7.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 31.5% of total assets.
C-Rad AB (publ) Competitors by Total Assets
Key competitors of C-Rad AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Bactiguard Holding AB (publ)
ST:BACTI-B
|
Sweden | Skr537.34 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
C-Rad AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.09 | 2.89 | 3.90 |
| Quick Ratio | 2.77 | 2.54 | 3.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr296.20 Million | Skr288.15 Million | Skr164.50 Million |
C-Rad AB (publ) - Advanced Valuation Insights
This section examines the relationship between C-Rad AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.68 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | 2.3% |
| Total Assets | Skr500.80 Million |
| Market Capitalization | $123.07 Million USD |
Valuation Analysis
Below Book Valuation: The market values C-Rad AB (publ)'s assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: C-Rad AB (publ)'s assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for C-Rad AB (publ) (2008–2025)
The table below shows the annual total assets of C-Rad AB (publ) from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr500.80 Million ≈ $53.89 Million |
+2.34% |
| 2024-12-31 | Skr489.36 Million ≈ $52.66 Million |
+21.13% |
| 2023-12-31 | Skr404.00 Million ≈ $43.48 Million |
+19.11% |
| 2022-12-31 | Skr339.17 Million ≈ $36.50 Million |
+10.59% |
| 2021-12-31 | Skr306.71 Million ≈ $33.01 Million |
+13.38% |
| 2020-12-31 | Skr270.52 Million ≈ $29.11 Million |
+71.44% |
| 2019-12-31 | Skr157.79 Million ≈ $16.98 Million |
+7.62% |
| 2018-12-31 | Skr146.61 Million ≈ $15.78 Million |
+24.19% |
| 2017-12-31 | Skr118.06 Million ≈ $12.70 Million |
+15.63% |
| 2016-12-31 | Skr102.10 Million ≈ $10.99 Million |
+38.68% |
| 2015-12-31 | Skr73.63 Million ≈ $7.92 Million |
+1.32% |
| 2014-12-31 | Skr72.66 Million ≈ $7.82 Million |
+17.63% |
| 2013-12-31 | Skr61.77 Million ≈ $6.65 Million |
+62.03% |
| 2012-12-31 | Skr38.12 Million ≈ $4.10 Million |
-29.66% |
| 2011-12-31 | Skr54.20 Million ≈ $5.83 Million |
-20.08% |
| 2010-12-31 | Skr67.82 Million ≈ $7.30 Million |
+51.26% |
| 2009-12-31 | Skr44.84 Million ≈ $4.83 Million |
-7.33% |
| 2008-12-31 | Skr48.38 Million ≈ $5.21 Million |
-- |
About C-Rad AB (publ)
C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solut… Read more